News about

AstraZeneca enters collaboration with Regeneron to research, develop & commercialise new small molecule medicines to treat obesity

AstraZeneca enters collaboration with Regeneron to research, develop & commercialise new small molecule medicines to treat obesity

AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities. The companies will evenly split research and development costs and share equally in any future potential profits

| 28/07/2021 | By 243

Aindra Systems develops AI-based automated intelligent screening system for cancer treatment

Aindra Systems develops AI-based automated intelligent screening system for cancer treatment

The company's mission is to democratize access to quality healthcare and concentrating is to democratize access to quality healthcare and efforts on assisting in the early identification of cervical cancer with an affordable model, making early screening and care a reality, especially in rural India

| 28/07/2021 | By 677

Already approved drugs may be considered as new drug, if certain changes occur in active substance: DCGI

Already approved drugs may be considered as new drug, if certain changes occur in active substance: DCGI

The Drugs Controller General (India) has said that certain changes in the active substance of an approved drug may lead to change in drug specification and require validation of the manufacturing process

| 27/07/2021 | By 325

Glenmark Life Sciences to expand geographical markets and CDMO business

Glenmark Life Sciences to expand geographical markets and CDMO business

Glenmark Life Sciences Limited, a leading developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (API) in chronic therapeutic areas, is planning to expand geographical markets and to grow contract development and manufacturing organization (CDMO) business

| 27/07/2021 | By 735

NPPA releases revised price list of 631 products under five medical devices

NPPA releases revised price list of 631 products under five medical devices

The National Pharmaceutical Pricing Authority (NPPA) has released price listing of 631 medical devices, which falls under the five medical devices it capped trade margins at 70 per cent at the Price to Distributor (PTD) level earlier this month

| 26/07/2021 | By 400

DCGI classifies 80 in-vitro diagnostic medical devices under Medical Devices Rules

DCGI classifies 80 in-vitro diagnostic medical devices under Medical Devices Rules

The Drugs Controller General (India) has classified around 80 in-vitro diagnostic medical devices including analysers, instruments and softwares, under the Medical Devices Rules, 2017, based on the intended use, risk associated with the device and other parameters

| 26/07/2021 | By 342

Tvasta collaborates with Saint Gobain to develop India's first 3D-Printed Doffing Units for frontline healthcare worker

Tvasta collaborates with Saint Gobain to develop India's first 3D-Printed Doffing Units for frontline healthcare worker

Deep tech startup Tvasta Manufacturing Solutions, founded by IIT Madras Alumni, has collaborated with Saint-Gobain, a leading multinational company, to develop a 3D-printed Doffing Unit to protect India's healthcare workers in the frontlines against Covid-19. Two Doffing Units have already been launched with a third one under construction

| 24/07/2021 | By 305

DoP amends Drug Price Control Order to add price list norms for medical devices

DoP amends Drug Price Control Order to add price list norms for medical devices

The Department of Pharmaceuticals has amended the drug price regulation to include the form in which the medical devices firms have to submit a price list to the drug regulatory authority

| 24/07/2021 | By 186

AstraZeneca completes acquisition of Alexion Pharmaceuticals

AstraZeneca completes acquisition of Alexion Pharmaceuticals

AstraZeneca completed the acquisition of Alexion Pharmaceuticals, (Alexion). The closing of the acquisition marks the company's entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca

| 23/07/2021 | By 295

PAG to acquire control of Acme Formulation

PAG to acquire control of Acme Formulation

PAG yesterday announced that it has reached an agreement to acquire a controlling stake in Acme Formulation. It will invest approximately $145 million to acquire a controlling stake in the company, a statement said.

| 23/07/2021 | By 651

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members